Name: | PHYSICAL PHARMACEUTICA LLC |
Jurisdiction: | New York |
Legal type: | DOMESTIC LIMITED LIABILITY COMPANY |
Status: | Active |
Date of registration: | 12 Feb 2007 (18 years ago) |
Entity Number: | 3475435 |
ZIP code: | 10962 |
County: | Westchester |
Place of Formation: | New York |
Address: | 30 Ramland Road, Suite 105, Orangeburg, NY, United States, 10962 |
CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
68MG6 | Active | Non-Manufacturer | 2012-08-22 | 2024-03-05 | 2026-10-25 | 2022-11-21 | |||||||||||||||
|
POC | ROBERT A. BELLANTONE |
Phone | +1 914-885-0950 |
Fax | +1 914-885-0948 |
Address | 30 RAMLAND RD STE 105, ORANGEBURG, NY, 10962 2606, UNITED STATES |
Ownership of Offeror Information
Highest Level Owner | Information not Available |
---|
Immediate Level Owner | Information not Available |
---|
List of Offerors (0) | Information not Available |
---|
Name | Role | Address |
---|---|---|
C/O ROBERT BELLANTONE | DOS Process Agent | 30 Ramland Road, Suite 105, Orangeburg, NY, United States, 10962 |
Start date | End date | Type | Value |
---|---|---|---|
2024-10-03 | 2025-02-03 | Address | 30 Ramland Road, Suite 105, Orangeburg, NY, 10962, USA (Type of address: Service of Process) |
2013-02-06 | 2024-10-03 | Address | 67 DAVENPORT AVENUE, YONKERS, NY, 10710, 2810, USA (Type of address: Service of Process) |
2007-02-12 | 2013-02-06 | Address | 67 DAVENPORT AVENUE, YONKERS, NY, 10710, USA (Type of address: Service of Process) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
250203004365 | 2025-02-03 | BIENNIAL STATEMENT | 2025-02-03 |
241003001272 | 2024-10-03 | BIENNIAL STATEMENT | 2024-10-03 |
210203061116 | 2021-02-03 | BIENNIAL STATEMENT | 2021-02-01 |
190206060899 | 2019-02-06 | BIENNIAL STATEMENT | 2019-02-01 |
170213006114 | 2017-02-13 | BIENNIAL STATEMENT | 2017-02-01 |
150204006072 | 2015-02-04 | BIENNIAL STATEMENT | 2015-02-01 |
130206007044 | 2013-02-06 | BIENNIAL STATEMENT | 2013-02-01 |
110328002217 | 2011-03-28 | BIENNIAL STATEMENT | 2011-02-01 |
070914000060 | 2007-09-14 | CERTIFICATE OF PUBLICATION | 2007-09-14 |
070212000293 | 2007-02-12 | ARTICLES OF ORGANIZATION | 2007-02-12 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PO | AWARD | HHSF223201211187P | 2012-08-28 | 2014-09-03 | 2014-09-03 | |||||||||||||||||||||
|
Title | IGF::OT::IGF CLOSELY ASSOCIATED - RESEARCH - NANO PARTICLE INVESTIGATION |
NAICS Code | 541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
Product and Service Codes | B529: SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA |
Recipient Details
Recipient | PHYSICAL PHARMACEUTICA LLC |
UEI | TN5VSP5RQ513 |
Legacy DUNS | 078537371 |
Recipient Address | UNITED STATES OF AMERICA, 67 DAVENPORT RD, YONKERS, WESTCHESTER, NEW YORK, 10710 |
Loan Number | Loan Funded Date | SBA Origination Office Code | Loan Delivery Method | Borrower Street Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3130337709 | 2020-05-01 | 0202 | PPP | 30 RAMLAND ROAD SUITE 105, ORANGEBURG, NY, 10962 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3183518301 | 2021-01-21 | 0202 | PPS | 30 Ramland Rd Ste 105, Orangeburg, NY, 10962-2606 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Status | User ID | Name of Firm | Trade Name | UEI | Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Active | P1676239 | PHYSICAL PHARMACEUTICA LLC | - | TN5VSP5RQ513 | 30 RAMLAND RD S STE 105, ORANGEBURG, NY, 10962-2626 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name | Robert A. Bellantone |
Role | President |
Name | Jean B. Mauro |
Role | Vice President |
SBA Federal Certifications
HUBZone Certified | No |
Women Owned Certified | No |
Women Owned Pending | No |
Economically Disadvantaged Women Owned Certified | No |
Economically Disadvantaged Women Owned Pending | No |
Veteran-Owned Small Business Certified | No |
Veteran-Owned Small Business Joint Venture | No |
Service-Disabled Veteran-Owned Small Business Certified | No |
Service-Disabled Veteran-Owned Small Business Joint Venture | No |
Bonding Levels
Description | Construction Bonding Level (per contract) |
Level | $0 |
Description | Construction Bonding Level (aggregate) |
Level | $0 |
Description | Service Bonding Level (per contract) |
Level | $0 |
Description | Service Bonding Level (aggregate) |
Level | $0 |
NAICS Codes with Size Determinations by NAICS
Primary | Yes |
Code | 541713 |
NAICS Code's Description | Research and Development in Nanotechnology |
Buy Green | Yes |
Code | 541714 |
NAICS Code's Description | Research and Development in Biotechnology (except Nanobiotechnology) |
Buy Green | Yes |
Export Profile (Trade Mission Online)
Exporter | No |
Export Business Activities | (none given) |
Exporting to | (none given) |
Desired Export Business Relationships | (none given) |
Description of Export Objective(s) | (none given) |
Date of last update: 28 Mar 2025
Sources: New York Secretary of State